AKERS BIOSCIENCES, INC. (NASDAQ:AKER) Files An 8-K Other Events

AKERS BIOSCIENCES, INC. (NASDAQ:AKER) Files An 8-K Other Events
Item 8.01 Other Events.

A hearing to determine whether to approve a proposed class action settlement concerning certain purchasers of the shares of Akers Biosciences, Inc. common stock, no par value, originally scheduled for November 8, 2019 at 2:30 P.M. New York Time, has been rescheduled. The hearing will be held on December 20, 2019, at 11 A.M New York Time, before the Honorable Esther Salas, United States District Judge of the District of New Jersey, Martin Luther King Building & U.S. Courthouse, 50 Walnut Street, Courtroom 5A, Newark, New Jersey 07101.

If you have any questions about the Settlement, you may call or write to Lead Counsel or to the Claims Administrator:

THE ROSEN LAW FIRM, P.A.

Laurence M. Rosen, Esq.

609 W. South Orange Avenue, Suite 2P

South Orange, NJ 07079

Tel: (973) 313-1887

Fax: (973) 833-0399

Akers Biosciences, Inc. Securities Litigation

c/o Strategic Claims Services

P.O. Box 230

600 N. Jackson St., Ste. 205

Media, PA 19063

Tel.: 866-274-4004

Fax: 610-565-7985

[email protected]

An ad to help with our costs